A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY TO EVALUATE THE SAFETY AND EFFECT OF CINRYZE (C1 ESTERASE INHIBITOR [HUMAN]) FOR THE TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION IN RECIPIENTS OF DONOR-SENSITIZED KIDNEY TRANSPLANTS
|Effective start/end date||5/1/12 → 6/30/14|
- ViroPharma Incorporated
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.